News

Emulsifiers alter gut bacteria in mice, set the stage for IBD and metabolic syndrome


 

FROM NATURE

References

The emulsifiers found in processed foods can alter the composition of gut microbiota and trigger intestinal inflammation that, in turn, may promote the development of inflammatory bowel disease and metabolic syndrome, Dr. Benoit Chassaing, PhD, of Georgia State University Institute for Biomedical Sciences, and his colleagues report Feb. 25 in Nature.

This photo shows bacteria that are present deeper in the mucus layer that lines the intestine and closer to the epithelium than they should be. Dr. Benoit Chassaing

This photo shows bacteria that are present deeper in the mucus layer that lines the intestine and closer to the epithelium than they should be.

The research team fed mice polysorbate 80 and carboxymethylcellulose, two commonly used emulsifiers, at doses replicating those found in processed foods. Emulsifier consumption changed the composition of the gut microbiota in the mice, resulting in a proinflammatory state. The bacteria were able to digest and infiltrate the intestine’s mucosal layer and the altered bacterial species expressed more flagellin and lipopolysaccharide, which can activate proinflammatory gene expression by the immune system.

The bacterial changes triggered chronic colitis in mice genetically prone to the disorder. In mice with normal immune systems, low-grade intestinal inflammation resulted, and metabolic syndrome was noted.

Transplanting the microbiota from mice fed emulsifiers to germ-free mice also transferred some parameters of low-grade inflammation and metabolic syndrome, indicating a central role for the microbiota in mediating the adverse effect of emulsifiers.

Recommended Reading

Screen for Barrett’s in all with central obesity?
MDedge Endocrinology
Reoperative bariatric surgery yields low complication rates, substantial weight loss at 1 year
MDedge Endocrinology
Monitor elderly for bone loss after gastric bypass
MDedge Endocrinology
Monitor elderly for bone loss after gastric bypass
MDedge Endocrinology
Long-term benefits shown after gastric banding
MDedge Endocrinology
VIDEO: Pediatric NAFLD worsens as kids age
MDedge Endocrinology
FDA approves IV antibacterial for complicated UTIs, abdominal infections
MDedge Endocrinology
FDA approves vagal blocking device for obesity
MDedge Endocrinology
Postop pancreatectomy complications most deadly in elderly
MDedge Endocrinology
Improved version of gastric stimulator for gastroparesis approved as humanitarian device
MDedge Endocrinology